Max Healthcare Institute Limited (“Max Healthcare”) is one of India’s largest healthcare organizations. We operate 22 healthcare facilities (5000+ beds), 30+ specialities and 5000+ clinicians across the NCR Delhi, Haryana, Punjab, Uttarakhand Maharashtra and Uttar Pradesh. Almost 85% of our bed capacity is in Metro/Tier 1 cities. Apart from hospitals, Max Healthcare also operates a homecare business and pathology business under brand names Max@Home and Max Labs respectively. Max@Home offers health and wellness services at home while Max Lab provides Pathology Services outside our hospital network.
Previous Close
1167.70
TTM EPS
10.89
52 Week High
1194.60
TTM PE
108.36
52 Week Low
630.90
P/B
13.65
Sector PE
99.33
Mkt Cap (Rs. Cr.)
114,716
(Source: Moneycontrol, BSE, Fisdom Research)
Technical Outlook
MAXHEALTH on the weekly chart has witnessed a Triangle pattern breakout above 1110 levels and prices sustained above the same.
The counter is trading in a higher high higher low formation on the broader time frame.
Momentum Indicator RSI (14) is reading in a bullish range shift zone between 50 – 70 levels with a bullish crossover.
Stock has been trading above 10, 21, and 50 EMA on the weekly chart maintaining the bullish momentum.
On April 4, 2022 the merger of India’s largest Housing Finance Company, HDFC Limited and the largest private sector bank in India, HDFC Bank was announced. As of September 30, 2024, the Bank’s distribution network was at 9,092 branches and 20,993 ATMs across 4,088 cities / towns as against 7,945 branches and 20,596 ATMs across 3,836 cities / towns as of September 30, 2023. 51% of our branches are in semiurban and rural areas. The Bank’s international operations comprises four branches in Hong Kong, Bahrain, Dubai and an IFSC Banking Unit (IBU) in Gujarat International Finance Tech City. It has five representative offices in Kenya, Abu Dhabi, Dubai, London and Singapore.
Previous Close
1859.25
TTM EPS
90.49
52 Week High
1880.00
TTM PE
20.68
52 Week Low
1363.55
P/B
3.16
Sector PE
19.57
Mkt Cap (Rs. Cr.)
14,30,928
(Source: Moneycontrol, BSE, Fisdom Research)
Technical Outlook
HDFCBANK on the weekly chart has witnessed a Rectangle pattern breakout and prices sustained above the same.
Recently the counter has given a two-year trading range breakout above 1775 levels which is positive for the stock.
Momentum Indicator RSI (14) is reading in a bullish range shift zone between 50 – 70 levels with a bullish crossover.
Stock has been trading above 10, 21, and 50 EMA on the weekly chart maintaining the bullish momentum.
Disclaimer: This document is not intended for anyone other than the recipient. The contents of this document may not be reproduced or further distributed to any person or entity, whether in whole or in part, for any purpose. If you have received the publication in error please notify the sender immediately. If you are not the named addressee, you should not disseminate, distribute or copy this document. You are hereby notified that disclosing, copying, distributing or taking any action in reliance on the contents of this information is strictly prohibited. All non-authorised reproduction or use of this document will be the responsibility of the user and may lead to legal proceedings. This document has no contractual value and is not and should not be construed as advice or as an offer or the solicitation of an offer or a recommendation to take action in consonance in any jurisdiction. Finwizard Technology Private Limited (“Fisdom”) makes no guarantee, representation or warranty and accepts no responsibility or liability for the accuracy or completeness of the information and/or opinions contained in this document, including any third party information obtained from sources it believes to be reliable but which has not been independently verified. In no event will Fisdom be liable for any damages, losses or liabilities including without limitation, direct or indirect, special, incidental, consequential damages, losses or liabilities, in connection with your use of this document or your reliance on or use or inability to use the information contained in this document, even if you advise us of the possibility of such damages, losses or expenses. Fisdom does not undertake any obligation to issue any further publications or update the contents of this document. The information stated and/or opinion(s) expressed herein are expressed solely as general commentary for general information purposes only and do not constitute advice, solicitation or recommendation to act upon thereof. Fisdom does not have regard to specific investment objectives, financial situation and the particular needs of any specific person who may receive this document. The information contained within this document has not been reviewed in the light of your personal circumstances. Please note that this information is neither intended to aid in decision making for legal, financial or other consulting questions, nor should it be the basis of any investment or other decisions. Fisdom may have issued other similar documents that are inconsistent with and reach different conclusion from the information presented in this document. The relevant offering documents should be read for further details. You should make such researches/inspections/inquiries as it deems necessary to arrive at an independent evaluation of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks involved. Fisdom makes no representations that the offerings mentioned in this document are available to persons of any other country or are necessarily suitable for any particular person or appropriate in accordance with their local law. Among other things, this means that the disclosures set forth in this document may not conform to rules of the regulatory bodies of any other country and investment in the offer discussed will not afford the protection offered by the local regulatory regime in any other country. Past performance contained in this document is not a reliable indicator of future performance whilst any forecasts, projections and simulations contained herein should not be relied upon as an indication of future results. The historical performance presented in this document is not indicative of and should not be construed as being indicative of or otherwise used as a proxy for future or specific investments. The relevant product documents should be read for further details. Fisdom does not undertake any obligation to issue any further publications to you or update the contents of this document and such contents are subject to changes at anytime.
Share the article
Array
Get exclusive content
and expert advice
Subscribe to fisdom to get regular updates in the finance world delivered to your inbox each month
